Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan F Moore

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
Necrobiosis lipoidica: an important cutaneous manifestation of diabetes that may respond to antiplatelet therapyAllan F Moore, Nicolas N Abourizk
Annual Review of Medicine|October 17, 2007
Genetic susceptibility to type 2 diabetes and implications for antidiabetic therapyAllan F Moore, Jose C Florez
The Journal of Clinical Endocrinology and Metabolism|September 8, 2007
A dural taleAllan F Moore, Steven K Grinspoon
Thyroid : Official Journal of the American Thyroid Association|August 24, 2007
Sunitinib (sutent)-induced thyrotoxicosis due to destructive thyroiditis: a case reportJason E Faris, Allan F Moore, Gilbert H Daniels
Diabetes Care|May 23, 2009
Genetic architecture of type 2 diabetes: recent progress and clinical implicationsRichard W Grant, Allan F Moore, Jose C Florez
Diabetes Care|May 1, 2008
Psoriatic exacerbation associated with insulin therapyAllan F Moore, Tiffany Soper, Natalie Jones, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
An unusual case of primary hyperparathyroidism with profoundly elevated parathyroid hormone levelsAllan F Moore, Tamara L Wexler, Rachel L Yung, et al.
Diabetes|June 12, 2008
Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention programAllan F Moore, Kathleen A Jablonski, Jarred B McAteer, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2008
The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention programAllan F Moore, Kathleen A Jablonski, Clinton C Mason, et al.
Plos One|March 27, 2015
The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetesGeoffrey A Walford, Natalia Colomo, Jennifer N Todd, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
Necrobiosis lipoidica: an important cutaneous manifestation of diabetes that may respond to antiplatelet therapyAllan F Moore, Nicolas N Abourizk
Annual Review of Medicine|October 17, 2007
Genetic susceptibility to type 2 diabetes and implications for antidiabetic therapyAllan F Moore, Jose C Florez
The Journal of Clinical Endocrinology and Metabolism|September 8, 2007
A dural taleAllan F Moore, Steven K Grinspoon
Thyroid : Official Journal of the American Thyroid Association|August 24, 2007
Sunitinib (sutent)-induced thyrotoxicosis due to destructive thyroiditis: a case reportJason E Faris, Allan F Moore, Gilbert H Daniels
Diabetes Care|May 23, 2009
Genetic architecture of type 2 diabetes: recent progress and clinical implicationsRichard W Grant, Allan F Moore, Jose C Florez
Diabetes Care|May 1, 2008
Psoriatic exacerbation associated with insulin therapyAllan F Moore, Tiffany Soper, Natalie Jones, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
An unusual case of primary hyperparathyroidism with profoundly elevated parathyroid hormone levelsAllan F Moore, Tamara L Wexler, Rachel L Yung, et al.
Diabetes|June 12, 2008
Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention programAllan F Moore, Kathleen A Jablonski, Jarred B McAteer, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2008
The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention programAllan F Moore, Kathleen A Jablonski, Clinton C Mason, et al.
Plos One|March 27, 2015
The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetesGeoffrey A Walford, Natalia Colomo, Jennifer N Todd, et al.
Pageof 1